Search News

Corporate Industry Technology Medical Updates

FDA

Corporate
magAssist's extracorporeal ventricular assist device Debuts at 2021 China International Heart Failure Conference 2021-07-16
Corporate
First Patient with NyokAssist™ Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventi 2023-09-05
Corporate
magAssist's NyokAssist™️ granted Designation by the FDA as a Breakthrough Device 2023-08-17

Tabs： heart transfer, acute heart failure, MoyoAssist Extra-VAD, multi-organ failure, LVAD, life support technologies, 30 days life support, extracorporeal artificial hearts, Mechanical Circulatory Support, a fully magnetic levitation blood pump, future healthcare,